Scleromyxedema, a therapeutic dilemma

Julio Cesar Salas-Alanis, Brayant Martinez-Jaramillo, Minerva Gomez-Flores, Jorge Ocampo-Candiani

Research output: Contribution to journalArticlepeer-review

11 Citations (Scopus)


Scleromyxedema is characterized by indurated erythematous papules disseminated on the face, chest and limbs. About twenty cases treated with thalidomide, stem cells, melphalan and immunoglobulin with varying results have been described. We present the case of a 28-year-old male patient diagnosed with scleromyxedema not associated with monoclonal gammopathy, multi-treated with anti-leprosy drugs, UVA1, and thalidomide for 4 years with no improvement.

Original languageEnglish
Pages (from-to)215
Number of pages1
JournalIndian Journal of Dermatology
Issue number2
Publication statusPublished - 1 Apr 2015

All Science Journal Classification (ASJC) codes

  • Dermatology


Dive into the research topics of 'Scleromyxedema, a therapeutic dilemma'. Together they form a unique fingerprint.

Cite this